Phase 4 Fibrillation Clinical Trials
37 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–20 of 37 trials
Recruiting
Phase 4
COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation
Atrial Fibrillation
Ottawa Hospital Research Institute3,018 enrolled8 locationsNCT04642430
Recruiting
Phase 4
Single-stage Pulmonary Vein Isolation Combined With Percutaneous Left Atrial Appendage Occluder Implantation in Patients With Recent Onset Ischemic Stroke and Atrial Fibrillation
Atrial FibrillationIschemic Stroke
Medical University of Silesia240 enrolled2 locationsNCT06212674
Recruiting
Phase 4
Study on the Prevention of Atrial Fibrillation Recurrence After Ablation by Qidong Yixin Granule
Persistent Atrial Fibrillation
Sir Run Run Shaw Hospital846 enrolled5 locationsNCT07508618
Recruiting
Phase 4
Prevention of Postop Atrial Fibrillation Through Intraoperative Inducibility of Atrial Fibrillation and Amiodarone Treatment
Postoperative Atrial Fibrillation
Stanford University600 enrolled1 locationNCT03868150
Recruiting
Phase 4
MEdical Treatment in Idiopathic Ventricular Fibrillation Patients
Cardiac Arrest, Out-Of-HospitalIdiopathic Ventricular Fibrillation
Bo Gregers Winkel218 enrolled2 locationsNCT07405229
Recruiting
Phase 4
Colchicine's Effect on Inflammatory Markers
ColchicinePost-operative Atrial FibrillationInflammation in Cardiac Surgery+2 more
Ayesha Ather24 enrolled1 locationNCT07287345
Recruiting
Phase 4
Ondansetron for the Management of Atrial Fibrillation
Atrial Fibrillation
Indiana University80 enrolled3 locationsNCT05844501
Recruiting
Phase 4
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
Atrial FibrillationStroke
Population Health Research Institute2,270 enrolled105 locationsNCT03968393
Recruiting
Phase 4
Evaluation of Two Different Regimens of the Antiarrhythmic Drug Amiodarone to Maintain Normal Sinus Rhythm After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation
Persistent Atrial Fibrillation
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau312 enrolled1 locationNCT07273994
Recruiting
Phase 4
Epinephrine Dose: Optimal Versus Standard Evaluation Trial
Ventricular FibrillationSudden Cardiac ArrestCardiac Arrest, Out-Of-Hospital+1 more
Unity Health Toronto3,790 enrolled8 locationsNCT03826524
Recruiting
Phase 4
Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias
Persistent Atrial FibrillationParoxysmal Atrial FibrillationLong-standing Persistent Atrial Fibrillation
Vivek Reddy275 enrolled5 locationsNCT06765356
Recruiting
Phase 4
Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients
Critical IllnessNew Onset Atrial Fibrillation
Dr. Stephanie Sibley200 enrolled4 locationsNCT05829317
Recruiting
Phase 4
The Effect of Colchicine on the Occurrence of Atrial Fibrillation After Cardiac Surgery
Atrial FibrillationCoronary Artery DiseaseCoronary Artery Bypass Grafting+1 more
Tomsk Cardiology Research Institute140 enrolled1 locationNCT06798714
Recruiting
Phase 4
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
Atrial Fibrillation
University of Illinois at Chicago162 enrolled4 locationsNCT02347111
Recruiting
Phase 4
Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure
Left Atrial Appendage ClosureAspirinNonvalvular Atrial Fibrillation+2 more
OCEAN-SHD Study Group500 enrolled21 locationsNCT07125417
Recruiting
Phase 4
Preventing Stroke, Premature Death and Cognitive Decline in a Broader Community of Patients With Atrial Fibrillation
Atrial Fibrillation
University of Birmingham3,000 enrolled1 locationNCT04700826
Recruiting
Phase 4
Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE)
Chronic Kidney DiseasesAtrium; Fibrillation
Hospital Sirio-Libanes1,500 enrolled6 locationsNCT06402851
Recruiting
Phase 4
The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF)
Atrial Fibrillation Patients With Intermediate Stroke Risk
Yonsei University1,800 enrolled1 locationNCT04437654
Recruiting
Phase 4
Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation
Atrial Fibrillation (AF)Percutaneous Coronary Intervention (PCI)Oral Anticoagulation+1 more
Insel Gruppe AG, University Hospital Bern3,010 enrolled15 locationsNCT05955365
Recruiting
Phase 4
Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation
Atrial FibrillationStrokeAnticoagulant Adverse Reaction+1 more
China National Center for Cardiovascular Diseases4,374 enrolled1 locationNCT06108414